Cargando...
Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
Multiple categories of medications have been developed to manage lipid profiles and reduce the risk of cardiovascular events in patients with heart disease. However, currently marketed medications have not solved the problems associated with preventing and treating cardiovascular diseases completely...
Gardado en:
| Publicado en: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844254/ https://ncbi.nlm.nih.gov/pubmed/27143910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S82387 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|